Literature DB >> 12413192

The importance of routine HIV testing in the incarcerated population: the Rhode Island experience.

Amar A Desai1, E Timothy Latta, Anne Spaulding, Josiah D Rich, Timothy P Flanigan.   

Abstract

Routine HIV testing in the correctional setting offered to all inmates at entry has played an important role in the diagnosis of HIV in Rhode Island. Diagnosis and treatment of HIV in prisons can further public health goals of HIV control, prevention, and education. Routine HIV testing can be incorporated into primary and secondary prevention programs in correctional facilities. In Rhode Island, where HIV testing is routine at entry into the correctional facility, approximately one third of all persons who test positive are identified in the correctional facility. The proportion of males and females testing positive in the correctional facility versus those testing positive in other facilities has shown a gradual decrease, with positive female HIV tests declining more substantially in recent years. Specific groups, such as males, African Americans, and injection drug users continue to be more likely diagnosed in the state correctional facility than in other testing sites. These differences may reflect barriers to health care access that other community initiatives have failed to address.

Entities:  

Mesh:

Year:  2002        PMID: 12413192     DOI: 10.1521/aeap.14.7.45.23867

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  30 in total

1.  Implementing opt-out programs at Los Angeles county jail: a gateway to novel research and interventions.

Authors:  Mark Malek; Alexander R Bazazi; Garrett Cox; Germaine Rival; Jacques Baillargeon; Armidia Miranda; Josiah D Rich
Journal:  J Correct Health Care       Date:  2011-01

2.  Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program.

Authors:  Amy Nunn; Alexandra Cornwall; Jeannia Fu; Lauri Bazerman; Helen Loewenthal; Curt Beckwith
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

3.  Incidence of sexually transmitted infections among hazardously drinking women after incarceration.

Authors:  Michael D Stein; Celeste M Caviness; Bradley J Anderson
Journal:  Womens Health Issues       Date:  2011-08-10

Review 4.  Managing HIV/AIDS in correctional settings.

Authors:  Sandra A Springer; Frederick L Altice
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

5.  Willingness to receive an HIV vaccine among incarcerated persons.

Authors:  Michelle Lally; Melissa Gaitanis; Snigdha Vallabhaneni; Steven Reinert; Kenneth Mayer; Gregory Zimet; Josiah Rich
Journal:  Prev Med       Date:  2006-07-27       Impact factor: 4.018

Review 6.  HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response.

Authors:  Theodore M Hammett
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

7.  Barriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities.

Authors:  Laura B Moyer; Kimberley C Brouwer; Stephanie K Brodine; Rebeca Ramos; Remedios Lozada; Michelle Firestone Cruz; Carlos Magis-Rodriguez; Steffanie A Strathdee
Journal:  Drug Alcohol Rev       Date:  2008-01

8.  Young incarcerated men's perceptions of and experiences with HIV testing.

Authors:  Deborah Kacanek; Gloria D Eldridge; Jill Nealey-Moore; Robin J MacGowan; Diane Binson; Timothy P Flanigan; Christine C Fitzgerald; James M Sosman
Journal:  Am J Public Health       Date:  2007-05-30       Impact factor: 9.308

9.  Treating drug abuse and addiction in the criminal justice system: improving public health and safety.

Authors:  Redonna K Chandler; Bennett W Fletcher; Nora D Volkow
Journal:  JAMA       Date:  2009-01-14       Impact factor: 56.272

10.  Preventive healthcare for underserved women: results of a prison survey.

Authors:  Ank E Nijhawan; Rachel Salloway; Amy S Nunn; Michael Poshkus; Jennifer G Clarke
Journal:  J Womens Health (Larchmt)       Date:  2010-01       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.